Literature DB >> 21269611

Laparoscopic excision of malignant struma ovarii and 1 year follow-up without further treatment.

Bernhard Kraemer1, Eva-Maria Grischke, Annette Staebler, Petros Hirides, Ralf Rothmund.   

Abstract

OBJECTIVE: To report the case of a patient with malignant struma ovarii, which was excised endoscopically.
DESIGN: Case study and literature review.
SETTING: Hospital outpatient clinic with subsequent hospitalization. PATIENT(S): A 40-year-old gravida 5, para 3 with an incidental ultrasonographic finding of a solid right adnexal mass. INTERVENTION(S): Endoscopic resection and 1-year follow-up. MAIN OUTCOME MEASURE(S): Treatment options and differential diagnosis. RESULT(S): The tumor was excised endoscopically. CONCLUSION(S): Malignant struma ovarii is a very rare, highly specialized form of mature ovarian teratoma, in which thyroid tissue is the predominant element. Because of the nonspecific symptoms and a lack of specific features in imaging studies, preoperative diagnosis is very difficult, and there is no standard treatment. Struma ovarii, which is potentially malignant, should be included in the differential diagnosis of an ovarian mass with cystic, solid, or mixed cystic and solid structure. Standardized treatment of malignant struma ovarii still remains undefined; currently the laparoscopic removal of the tumor may be a treatment option, and thyroidectomy and radiotherapy with 131I should be offered.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21269611     DOI: 10.1016/j.fertnstert.2010.12.047

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Struma ovarii. A case report.

Authors:  P Tanimanidis; K Chatzistamatiou; A Nikolaidou; K Kaplanis
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

Review 2.  Case Report: Recurrent Malignant Struma Ovarii With Hyperthyroidism and Metastases, A Rare Case Report and Review of the Literature.

Authors:  Ruyi Zhang; Xin Tian; Ying Luo; Haiwei Dong; Weijun Tian; Yujie Zhang; Dong Li; Haoran Sun; Zhaowei Meng
Journal:  Pathol Oncol Res       Date:  2022-05-10       Impact factor: 2.874

3.  Struma ovarii with follicular thyroid-type carcinoma and neuroendocrine component: case report.

Authors:  Federico Selvaggi; Domenico Risio; Mathew Waku; Daniela Simo; Domenico Angelucci; Alberto D'Aulerio; Roberto Cotellese; Paolo Innocenti
Journal:  World J Surg Oncol       Date:  2012-05-21       Impact factor: 2.754

4.  The largest reported papillary thyroid carcinoma arising in struma ovarii and metastasis to opposite ovary: case report and review of literature.

Authors:  Mohamed S Al Hassan; Tamer Saafan; Walid El Ansari; Afaf A Al Ansari; Mahmoud A Zirie; Hanan Farghaly; Abdelrahman Abdelaal
Journal:  Thyroid Res       Date:  2018-07-24

5.  Unusual Case of Malignant Struma Ovarii and Cervical Thyroid Cancer Preceded by Ovarian Teratoma: Case Report and Review of the Literature.

Authors:  Elias G Tzelepis; Elena Barengolts; Steven Garzon; Joseph Shulan; Yuval Eisenberg
Journal:  Case Rep Endocrinol       Date:  2019-03-17

6.  Successful in vitro fertilization pregnancy and delivery after a fertility-sparing laparoscopic operation in a patient with a papillary thyroid carcinoma arising from a mature cystic teratoma.

Authors:  Kirim Hong; Anthony Kyung Woo Han; Mi-La Kim; Bo Seong Yun; Hye Sun Jun; Seok Ju Seong; Jeong Yun Shim
Journal:  Clin Exp Reprod Med       Date:  2019-08-12

7.  Struma ovarii with contralateral ovarian teratoma: A case report.

Authors:  Xinjie Ren; Zhaoyou Guo; Jiao Bai
Journal:  Front Surg       Date:  2022-08-19

8.  Papillary Thyroid Cancer in a Struma Ovarii in a 17-Year-Old Nulliparous Patient: A case Report.

Authors:  Agnieszka Gonet; Rafał Ślusarczyk; Danuta Gąsior-Perczak; Artur Kowalik; Janusz Kopczyński; Aldona Kowalska
Journal:  Diagnostics (Basel)       Date:  2020-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.